drugset / Trial / NCT04604899
Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa
Phase 2
Completed
30 enrolled
jCyte, Inc
California Institute for Regenerative Medicine (CIRM) · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary objective of the study is to assess the safety of repeat injection of human retinal progenitor cells (jCell) in adult subjects with RP that have previously been treated with jCell.
Timeline
- Start
- 2020-12-01
- Primary completion
- 2022-03-22
- Completion
- 2022-03-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human retinal progenitor cells | Cell therapy | 6 cells | Intravitreal |